Not enough.. expected more than 12% quarter on quarter since this should have included receipts from Blue Reef. Changed my sentiment to HOld. Also, if receipts do not improve for next quarter a CR will be on the cards by Feb/Mar.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025